Haemonetics to Acquire Medical Device Company Attune Medical
Haemonetics Corporation announced on March 5 that it has entered into a definitive agreement to acquire privately-held Chicago-based Attune Medical. Under the terms of the agreement, Haemonetics will acquire Attune Medical for an upfront cash payment of $160 million at closing plus additional contingent consideration based on sales growth in the three years following the consummation of the transaction and the achievement of other milestones. Attune Medical is a provider of a medical device, the ensoETM® proactive esophageal cooling device, used to control the core temperature of the patient’s body. ensoETM is the only FDA-cleared temperature regulation device indicated for... Read More »
Halma Expands Health Tech Portfolio With Rovers Medical Devices
Halma plc announced on March 4 the acquisition of Rovers Medical Devices BV for an initial cash consideration of €85 million ($91.8 million USD), with additional payments of up to €6 million (about $6.5 million) pending future performance. The acquisition is expected to strengthen Halma’s market position by broadening its healthcare technology offerings. Rovers Medical Devices is involved in the development, production and world-wide sales of medical devices with a focus on cell sampling devices. The company had a revenue of €12 million (about $13 million USD) for the 12 months ending December 31, 2023, according to the original deal press release. Halma is a global group of... Read More »
Boston Scientific Posts Strong Results for Q4 2023
Boston Scientific announced its fourth quarter and full year 2023 results the morning of Wednesday, January 31. The company’s revenue for the quarter rose 15% from $3.2 billion during Q4 2022, to $3.7 billion. For the full year 2023, the company generated net sales of $14.2 billion, growing 12% over the $12.7 billion generated during full year 2022. For Q1 2024, Boston Scientific expects sales to increase 7% to 9% on an organic basis. The company’s first-quarter sales guidance is impressive as its stock hit a record high. Boston Scientific’s stock jumped a little more than 3% from $61.43 to $63.47 in afternoon trades on the stock market the day of the announcement. ... Read More »
Lion Street Medical Purchases Pensar Medical
Lion Street Medical has announced the successful acquisition of Pensar Medical, a Norco, California-based medical device company specializing in wound care. Founded in 2012, Pensar Medical specializes in Negative Pressure Wound Therapy (NPWT) systems, including WoundPro, the industry’s most powerful and durable pump, and MicroDoc, a disposable unit for single-use NPWT. The company also offers wound care supplies, including collection canisters and foam dressing kits. Lion Street Medical is a leading national financial services company comprised of over 200 independent firms that specialize in design and planning for high-net-worth and corporate clients. The company is... Read More »
Shore Capital Partners Acquires Cook Medical Assets
Shore Capital Partners announced on January 24 that it completed a partnership with C2Dx, a medical device company based in Kalamazoo, Michigan. In addition to this partnership, Shore Capital Partners announced it, and C2Dx, was acquiring the Otolaryngology/Head and Neck Surgery (OHNS) family of products from Cook Medical. The OHNS assets provide minimally invasive procedures for ear, nose and throat surgeons to help treat obstructive salivary disease, chronic ear disorders, nasal/sinus and skull base reconstruction and dysphagia. Shore Capital Partners is a Chicago-based healthcare-focused lower middle-market private equity firm with offices in Nashville. It has approximately... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
